Macrophages and extracellular matrix in breast cancer: partners in crime or protective allies? by Deligne, C, Midwood, KIM

Impact of depleting therapeutic monoclonal antibodies on the host adaptive immunity: a bonus or a malus? by Deligne, C, Milcent, B, Josseaume, N, Teillaud, J, Sibéril, S

Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression by Murdamoothoo, D, Sun, Z, Yilmaz, A, Deligne, C, Midwood, K

Chapter 21 - How to detect and purify tenascin-C by Giblin, S, Murdamoothoo, D, Deligne, C, Schwenzer, A, Orend, G, Midwood, K

Investigating chemokine-matrix networks in breast cancer: tenascin-C sets the tone for CCL2 by Gschwandtner, M, Gammage, A, Deligne, C, Mies, L, Schwenzer, A, Midwood, KIM

Mapping tenascin-C interaction with toll-like receptor 4 reveals a new subset of endogenous inflammatory triggers by Zuliani-Alvarez, L, Marzeda, A, Deligne, C, Schwenzer, A, McCann, F, Marsden, B, Piccinini, A, Midwood, K

Tenascin-C increases lung metastasis by impacting blood vessel invasions by Sun, Z, Velázquez-Quesada, I, Murdamoothoo, D, Ahowesso, C, Yilmaz, A, Spenlé, C, Averous, G, Erne, W, Oberndorfer, F, Oszwald, A, Kain, R, Bourdon, C, Mangin, P, Deligne, C, Midwood, K, Abou-Faycal, C, Lefebvre, O, Klein, A, Van Der Heyden, M, Chenard, M, Christofori, G, Mathelin, C, Loustau, T, Hussenet, T, Orend, G